Journey Medical Corp (DERM)

$7.69 +0.28 (3.78%)
Market Cap 201.08M
Revenue (ttm) 56.13M
Net Income (ttm) -14.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26.14%
Debt to Equity Ratio 0.97
Volume 288,200
Avg Vol 176,752
Day's Range N/A - N/A
Shares Out 27.14M
Stochastic %K 16%
Beta 0.80
Analysts Strong Sell
Price Target $13.50

Company Profile

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 480 434 6670
Address:
9237 East Via de Ventura Boulevard, Suite 105, Scottsdale, United States
Iightning
Iightning Dec. 2 at 2:30 AM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $DERM **Contract:** Dec 19 $10C **Entry:** 1.35 **Exit:** 1.93 **Return:** **+42.92% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Iightning
Iightning Nov. 26 at 5:26 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $1.68 | Profit: 24.51% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 3:34 PM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $1.68 | Profit: 24.51% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:29 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $1.68 | Profit: 24.51% ROI | https://1ightning.com
0 · Reply
NiceBuzz
NiceBuzz Nov. 24 at 4:37 AM
$DERM buying heavy here.
0 · Reply
Iightning
Iightning Nov. 22 at 1:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $2.56 | Profit: 89.33% ROI | https://1ightning.com
0 · Reply
JFais
JFais Nov. 21 at 3:19 PM
$ARQT for $DERM all-stock would be genius
0 · Reply
JFais
JFais Nov. 21 at 3:15 PM
$ARQT for $DERM all-stock would be genius
0 · Reply
Iightning
Iightning Nov. 21 at 5:02 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $2.56 | Profit: 89.33% ROI | https://1ightning.com
0 · Reply
Tomasini
Tomasini Nov. 20 at 3:44 PM
$DERM anyone having trouble buying? schwab wont let me
0 · Reply
Latest News on DERM
Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:31 PM EST - 21 days ago

Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Nov 12, 2025, 4:01 PM EST - 21 days ago

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Nov 5, 2025, 8:30 AM EST - 4 weeks ago

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

FBIO

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

Oct 24, 2025, 8:30 AM EDT - 5 weeks ago

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

FBIO

Journey Medical Corporation to Participate in October 2025 Investor Conferences

Oct 8, 2025, 8:30 AM EDT - 2 months ago

Journey Medical Corporation to Participate in October 2025 Investor Conferences

FBIO

Journey Medical: EMROSI's Ramp Puts Profitability On The Horizon

Sep 6, 2025, 8:44 AM EDT - 3 months ago

Journey Medical: EMROSI's Ramp Puts Profitability On The Horizon

Journey Medical Corporation to Participate in September 2025 Investor Conferences

Sep 3, 2025, 8:30 AM EDT - 3 months ago

Journey Medical Corporation to Participate in September 2025 Investor Conferences

FBIO

Journey Medical Corporation to Present at the Emerging Growth Conference

Aug 18, 2025, 8:30 AM EDT - 3 months ago

Journey Medical Corporation to Present at the Emerging Growth Conference

FBIO

CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Aug 13, 2025, 8:35 AM EDT - 4 months ago

CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

CAVA CRWV

Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 6:42 PM EDT - 4 months ago

Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 12, 2025, 4:01 PM EDT - 4 months ago

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

Aug 7, 2025, 8:30 AM EDT - 4 months ago

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

FBIO

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Aug 5, 2025, 4:01 PM EDT - 4 months ago

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

FBIO

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

Jul 14, 2025, 8:30 AM EDT - 5 months ago

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

FBIO

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

Jun 24, 2025, 8:30 AM EDT - 5 months ago

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

FBIO

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

Jun 20, 2025, 8:30 AM EDT - 5 months ago

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

FBIO

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

Jun 9, 2025, 8:30 AM EDT - 6 months ago

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

FBIO

Journey Medical Corporation (DERM) Q1 2025 Earnings Call Transcript

May 14, 2025, 7:08 PM EDT - 7 months ago

Journey Medical Corporation (DERM) Q1 2025 Earnings Call Transcript

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025, 4:01 PM EDT - 7 months ago

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

May 7, 2025, 4:01 PM EDT - 7 months ago

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

FBIO

Top 3 Health Care Stocks That May Crash In Q2

Apr 7, 2025, 11:23 AM EDT - 8 months ago

Top 3 Health Care Stocks That May Crash In Q2

ALMS CMRX

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Apr 1, 2025, 4:01 PM EDT - 8 months ago

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

FBIO

Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 7:10 PM EDT - 9 months ago

Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Mar 26, 2025, 4:01 PM EDT - 9 months ago

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Mar 24, 2025, 8:30 AM EDT - 9 months ago

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

FBIO

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Mar 19, 2025, 4:01 PM EDT - 9 months ago

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

FBIO

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

Mar 12, 2025, 8:30 AM EDT - 9 months ago

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

FBIO

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

Mar 5, 2025, 4:01 PM EST - 9 months ago

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

FBIO

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

Mar 4, 2025, 4:01 PM EST - 9 months ago

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

FBIO

Stock Picks From Seeking Alpha's January 2025 New Analysts

Feb 5, 2025, 8:30 AM EST - 10 months ago

Stock Picks From Seeking Alpha's January 2025 New Analysts

ACIW ASML AUNA BE BITF BRAG BSY

Journey Medical Corporation: Emrosi's Launch Could Be A Turning Point

Jan 30, 2025, 9:18 AM EST - 10 months ago

Journey Medical Corporation: Emrosi's Launch Could Be A Turning Point

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Jan 23, 2025, 8:30 AM EST - 11 months ago

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

FBIO

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Nov 12, 2024, 4:01 PM EST - 1 year ago

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Nov 4, 2024, 7:00 AM EST - 1 year ago

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

FBIO

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Oct 25, 2024, 8:30 AM EDT - 1 year ago

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

FBIO

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 3, 2024, 8:30 AM EDT - 1 year ago

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

FBIO

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Sep 9, 2024, 8:30 AM EDT - 1 year ago

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

FBIO

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:15 AM EDT - 1 year ago

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FBIO

Journey Medical Corporation (DERM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 7:37 PM EDT - 1 year ago

Journey Medical Corporation (DERM) Q2 2024 Earnings Call Transcript

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Aug 12, 2024, 4:01 PM EDT - 1 year ago

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

FBIO

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

FBIO

Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase

May 15, 2024, 4:01 PM EDT - 1 year ago

Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase

FBIO

Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript

May 13, 2024, 10:43 PM EDT - 1 year ago

Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

May 13, 2024, 4:01 PM EDT - 1 year ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

FBIO

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

May 7, 2024, 8:30 AM EDT - 1 year ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

FBIO

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

May 1, 2024, 4:01 PM EDT - 1 year ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

FBIO

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Apr 25, 2024, 8:30 AM EDT - 1 year ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

FBIO

Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript

Mar 21, 2024, 8:22 PM EDT - 1 year ago

Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Mar 21, 2024, 4:01 PM EDT - 1 year ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

FBIO

Iightning
Iightning Dec. 2 at 2:30 AM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $DERM **Contract:** Dec 19 $10C **Entry:** 1.35 **Exit:** 1.93 **Return:** **+42.92% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Iightning
Iightning Nov. 26 at 5:26 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $1.68 | Profit: 24.51% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 3:34 PM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $1.68 | Profit: 24.51% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:29 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $1.68 | Profit: 24.51% ROI | https://1ightning.com
0 · Reply
NiceBuzz
NiceBuzz Nov. 24 at 4:37 AM
$DERM buying heavy here.
0 · Reply
Iightning
Iightning Nov. 22 at 1:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $2.56 | Profit: 89.33% ROI | https://1ightning.com
0 · Reply
JFais
JFais Nov. 21 at 3:19 PM
$ARQT for $DERM all-stock would be genius
0 · Reply
JFais
JFais Nov. 21 at 3:15 PM
$ARQT for $DERM all-stock would be genius
0 · Reply
Iightning
Iightning Nov. 21 at 5:02 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $2.56 | Profit: 89.33% ROI | https://1ightning.com
0 · Reply
Tomasini
Tomasini Nov. 20 at 3:44 PM
$DERM anyone having trouble buying? schwab wont let me
0 · Reply
Iightning
Iightning Nov. 20 at 2:46 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $2.56 | Profit: 89.33% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:37 AM
1ightning® Options Trade Alert (Actionable) | Buy $DERM Dec 19 $10 Call | Enter: $1.35 Exit: $2.56 | Profit: 89.33% ROI | https://1ightning.com
0 · Reply
buymoremakemore
buymoremakemore Nov. 17 at 3:44 PM
$DERM Hello again $8
2 · Reply
Tomasini
Tomasini Nov. 14 at 7:31 PM
$DERM a little short covering it seems
0 · Reply
buymoremakemore
buymoremakemore Nov. 14 at 6:24 PM
$DERM CDTX people got paid today. Maybe we see $100/sh one day here.
0 · Reply
buymoremakemore
buymoremakemore Nov. 14 at 5:54 PM
$DERM For tax purposes Im holding my 26000 shares with averages in $3 and $4 range because of how much ive made on other stocks this year. Will potentially average up potentially in low $7 range.
1 · Reply
Tomasini
Tomasini Nov. 14 at 5:37 PM
$DERM still high volume today. shorts having safe play with no news till next year unless we get avsurprise
0 · Reply
hamiltiongold
hamiltiongold Nov. 14 at 12:15 AM
$DERM $TGTX The bullish trend has become irreversible. https://stocktwits.com/hamiltiongold
0 · Reply
T_rader
T_rader Nov. 13 at 9:03 PM
$DERM who’s ready for the new trading range for the next 2 months? Going nowhere fast
0 · Reply
FinSUN
FinSUN Nov. 13 at 7:03 PM
$DERM accumulated. This is long.
0 · Reply
Tomasini
Tomasini Nov. 13 at 6:23 PM
$DERM good day to get some cheap shares for 2026
1 · Reply
MightyPumperDuck
MightyPumperDuck Nov. 13 at 5:37 PM
$DERM oddly enough, I sold a grip on the way up and now it’s waaaay below my selling point. A smoking opportunity to regain my overall position for a hefty discount. $9 is definitely not the floor. But, opportunity is upon is. Thank you for that.
0 · Reply